224 related articles for article (PubMed ID: 33580477)
21. Levetiracetam and cutaneous adverse reactions: A systematic review of descriptive studies.
Rashid M; Rajan AK; Chhabra M; Kashyap A
Seizure; 2020 Feb; 75():101-109. PubMed ID: 31931437
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous Adverse Drug Reactions (CADRs)-Statistical Analysis of the Causal Relationship between the Drug, Comorbidities, Cofactors, and the Cutaneous Reaction-A Single-Centered Study.
Machoń N; Lewandowska J; Zdanowska N; Placek W; Owczarczyk-Saczonek A
Int J Environ Res Public Health; 2022 Jun; 19(13):. PubMed ID: 35805639
[TBL] [Abstract][Full Text] [Related]
23. The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta-analysis.
Cohen H; Mahajna G; Ben-Shushan T; Matok I; Eyal S
Epilepsia; 2024 Feb; 65(2):445-455. PubMed ID: 38010146
[TBL] [Abstract][Full Text] [Related]
24. Incidence of Antiseizure Medication-Induced Severe Cutaneous Adverse Reactions in Malaysia.
Fong SL; Lim KS; Hariraj V; Lee SC; Wo WK; Ramli A; Ho JH; Lai PSM; Ng WL
J Clin Pharmacol; 2022 Aug; 62(8):983-991. PubMed ID: 35230712
[TBL] [Abstract][Full Text] [Related]
25. Movement disorders associated with antiseizure medications: A real-world disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System.
Zhou J; Wei Z; Chen S; Xie H; Huang W; Liu M; Wu X
Br J Clin Pharmacol; 2023 Nov; 89(11):3389-3400. PubMed ID: 37353394
[TBL] [Abstract][Full Text] [Related]
26. The impact of pregnancy on the pharmacokinetics of antiseizure medications: A systematic review and meta-analysis of data from 674 pregnancies.
Schoretsanitis G; Deligiannidis KM; Kasperk N; Schmidt CT; Kittel-Schneider S; Ter Horst P; Berlin M; Kohn E; Poels EMP; Zutshi D; Tomson T; Spigset O; Paulzen M
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jul; 133():111030. PubMed ID: 38762161
[TBL] [Abstract][Full Text] [Related]
27. Cutaneous Adverse Drug Reactions in a Tertiary Care Teaching Hospital in India: An Intensive Monitoring Study.
Thakkar S; Patel TK; Vahora R; Bhabhor P; Patel R
Indian J Dermatol; 2017; 62(6):618-625. PubMed ID: 29263536
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous adverse drug reactions in Indian population: A systematic review.
Patel TK; Thakkar SH; Sharma D
Indian Dermatol Online J; 2014 Dec; 5(Suppl 2):S76-86. PubMed ID: 25593813
[TBL] [Abstract][Full Text] [Related]
29. Adverse cutaneous drug reactions among hospitalized patients: five year surveillance.
Turk BG; Gunaydin A; Ertam I; Ozturk G
Cutan Ocul Toxicol; 2013 Mar; 32(1):41-5. PubMed ID: 22812902
[TBL] [Abstract][Full Text] [Related]
30. Tolerability of Antiseizure Medications in Individuals With Newly Diagnosed Epilepsy.
Alsfouk BAA; Brodie MJ; Walters M; Kwan P; Chen Z
JAMA Neurol; 2020 May; 77(5):574-581. PubMed ID: 32091535
[TBL] [Abstract][Full Text] [Related]
31. Retention of antiseizure medications for epilepsy in multiple sclerosis: A retrospective observational study.
Mahamud Z; Håkansson S; Burman J; Zelano J
Epilepsy Behav; 2021 Aug; 121(Pt A):108034. PubMed ID: 34004524
[TBL] [Abstract][Full Text] [Related]
32. Association of
John S; Balakrishnan K; Sukasem C; Anand TCV; Canyuk B; Pattharachayakul S
J Pers Med; 2021 Jul; 11(8):. PubMed ID: 34442381
[TBL] [Abstract][Full Text] [Related]
33. Adverse Skin Reactions with Antiepileptic Drugs Using Korea Adverse Event Reporting System Database, 2008-2017.
Kim HK; Kim DY; Bae EK; Kim DW
J Korean Med Sci; 2020 Feb; 35(4):e17. PubMed ID: 31997613
[TBL] [Abstract][Full Text] [Related]
34. Genome-wide mapping for clinically relevant predictors of lamotrigine- and phenytoin-induced hypersensitivity reactions.
McCormack M; Urban TJ; Shianna KV; Walley N; Pandolfo M; Depondt C; Chaila E; O'Conner GD; Kasperavičiūtė D; Radtke RA; Heinzen EL; Sisodiya SM; Delanty N; Cavalleri GL
Pharmacogenomics; 2012 Mar; 13(4):399-405. PubMed ID: 22379998
[TBL] [Abstract][Full Text] [Related]
35. The HLA-B*15:02 polymorphism and Tegretol
Chouchi M; Kaabachi W; Tizaoui K; Daghfous R; Aidli SE; Hila L
Rev Neurol (Paris); 2018 May; 174(5):278-291. PubMed ID: 29685430
[TBL] [Abstract][Full Text] [Related]
36. Genetic and clinical risk factors associated with phenytoin-induced cutaneous adverse drug reactions in Thai population.
Sukasem C; Sririttha S; Tempark T; Klaewsongkram J; Rerkpattanapipat T; Puangpetch A; Boongird A; Chulavatnatol S
Pharmacoepidemiol Drug Saf; 2020 May; 29(5):565-574. PubMed ID: 32134161
[TBL] [Abstract][Full Text] [Related]
37. Rash from antiepileptic drugs: influence by gender, age, and learning disability.
Alvestad S; Lydersen S; Brodtkorb E
Epilepsia; 2007 Jul; 48(7):1360-5. PubMed ID: 17484761
[TBL] [Abstract][Full Text] [Related]
38. Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies.
Kashyap A; Sreenivasan S; Rajan AK; Rashid M; Chhabra M
J Basic Clin Physiol Pharmacol; 2021 Mar; 33(3):327-346. PubMed ID: 33725760
[TBL] [Abstract][Full Text] [Related]
39. Cosmetic adverse effects of antiseizure medications; A systematic review.
Asadi-Pooya AA; Rostaminejad M; Zeraatpisheh Z; Mirzaei Damabi N
Seizure; 2021 Oct; 91():9-21. PubMed ID: 34052629
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]